GlassScriptPhysician profile
Jason Tharpe
NPI 1659636488
$11,180.47
in general payments reported to CMS, 2019-2025
36 companies · $2,314 in 2025
The $2,314 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,725 · 2022: $2,013 · 2023: $2,139 · 2024: $2,989 · 2025: $2,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,222 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,221.72 |
| Education | $221.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,379.55 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,184.06 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $1,014.58 | 2021-2025 | Adbry, Anzupgo |
| Pfizer INC. | $740.80 | 2021-2025 | |
| Galderma Laboratories, L.P. | $698.17 | 2021-2025 | Nemluvio, Aklief, Oracea |
| Novartis Pharmaceuticals Corporation | $667.68 | 2021-2025 | |
| Abbvie INC. | $654.75 | 2022-2025 | |
| Incyte Corporation | $642.35 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $614.35 | 2021-2025 | Tremfya, Stelara, Simponi |
| Regeneron Healthcare Solutions, INC. | $489.04 | 2021-2025 | Dupixent, Libtayo |
| Almirall LLC | $458.31 | 2021-2025 | Klisyri, Seysara |
| Ucb, INC. | $451.35 | 2021-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $347.67 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $323.07 | 2021-2025 | Blu-U, Odomzo |
| Lilly USA, LLC | $305.72 | 2021-2025 | Taltz, Olumiant |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Tharpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.